Mettler-Toledo International, Inc. $MTD Shares Bought by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 7.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715 shares of the medical instruments supplier’s stock after acquiring an additional 616 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Mettler-Toledo International were worth $10,664,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Versant Capital Management Inc lifted its position in Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 8 shares during the period. SJS Investment Consulting Inc. increased its position in shares of Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 27 shares during the period. Root Financial Partners LLC bought a new stake in shares of Mettler-Toledo International in the 3rd quarter worth $42,000. Salomon & Ludwin LLC bought a new stake in shares of Mettler-Toledo International in the 3rd quarter worth $43,000. Finally, Quantbot Technologies LP acquired a new stake in shares of Mettler-Toledo International in the third quarter valued at $49,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the sale, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.77% of the company’s stock.

Mettler-Toledo International Stock Up 0.6%

Shares of NYSE MTD opened at $1,174.59 on Monday. The stock’s fifty day simple moving average is $1,378.52 and its 200 day simple moving average is $1,369.11. The stock has a market capitalization of $23.88 billion, a price-to-earnings ratio of 27.89, a PEG ratio of 2.46 and a beta of 1.43. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the business posted $12.41 earnings per share. Mettler-Toledo International’s revenue was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Analysts Set New Price Targets

MTD has been the subject of several research reports. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Wall Street Zen upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a report on Monday, December 15th. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Finally, Barclays dropped their target price on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a report on Monday, December 15th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $1,435.42.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.